Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PTC to sell spinal muscular atrophy drug royalties for $1B
PTC to sell spinal muscular atrophy drug royalties for $1B
PTC to sell spinal muscular atrophy drug royalties for $1B
Submitted by
admin
on October 19, 2023 - 11:34am
Source:
BioPharma Dive
News Tags:
PTC Therapeutics
spinal muscular atrophy
Evrysdi
Royalty Pharma
Headline:
PTC to sell spinal muscular atrophy drug royalties for $1B
snippet:
PTC Therapeutics has agreed to sell a big chunk of its remaining royalty stream from the spinal muscular atrophy drug Evrysdi to Royalty Pharma for $1 billion.
Do Not Allow Advertisers to Use My Personal information
